Company intelligence / Profile preview

Vensica Therapeutics

Netanya, Central District, Israelprnewswire.com ↗

Ownership: Private
Employees: ~11
Development stage: Phase 2

Overview

Vensica has completed a successful Phase IIa clinical trial for its lead program combining Xeomin® (incobotulinumtoxinA) with the proprietary, needle-free, ultrasound-based device "Vibe" for overactive bladder. The company is preparing multicenter Phase 2 trials in Europe and the US. Early results show promising safety and usability, with the technology aiming to improve patient experience by avoiding painful needle injections and enabling more uniform drug delivery to the bladder wall.

Therapeutic areas: OncologyNephrologyNeurologyUrology
Modalities: Protein (botulinum toxin A)Device (ultrasound-assisted drug delivery)Biologic (for future pipeline expansion)
Industry: Biotech

Drug pipeline

1 asset

ViXe

Unknown

Partnerships

Merz Therapeutics – exclusive global partnership/licensing agreement on botulinum neurotoxin A supply and co-development support. Merz is also an investor and board member.Laborie – strategic investor, global urology medical device company.Israel Biotech Fund – lead investor.

Beyond the preview

Go deeper on Vensica Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vensica Therapeutics.

Explore the full profile